Latest Global Immuno-Oncology Landscape Report From the Cancer Research Institute Published in Nature Reviews Drug Discovery
September 27, 2019
September 27, 2019
NEW YORK, Sept. 27 -- Cancer Research Institute issued the following news:
The Cancer Research Institute (CRI), a nonprofit organization dedicated to the discovery and development of powerful immunotherapies for all cancers, announced today the publication of an updated report that provides a comprehensive, independent analysis of the global landscape of cancer immunotherapy, including all agents from preclinical to marketed stages.
Titled "Immuno-Oncology Drug Dev . . .
The Cancer Research Institute (CRI), a nonprofit organization dedicated to the discovery and development of powerful immunotherapies for all cancers, announced today the publication of an updated report that provides a comprehensive, independent analysis of the global landscape of cancer immunotherapy, including all agents from preclinical to marketed stages.
Titled "Immuno-Oncology Drug Dev . . .